Piramal Enterprises Ltd Analyst Rating
based on 7 analysts
14.29%
Buy
28.57%
Hold
57.14%
Sell
Based on 7 analysts offering long term price targets for Piramal Enterprises Ltd. An average target of ₹961.43
Source: S&P Global Market Intelligence
Piramal Enterprises Ltd Share analysis
Piramal Enterprises Ltd price forecast by 7 analysts
Downside of
High
₹1150
Target
₹961.43
Low
₹800
Piramal Enterprises Ltd target price ₹961.43, a slight downside of -11.43% compared to current price of ₹1085.5. According to 7 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Piramal Enterprises Ltd revenue growth forecast
Expected growth rate Q1, FY2026:
Forecast
Actual
Including amortisation and stock based compensations
Piramal Enterprises Ltd EPS growth forecast
EPS estimate Q1, FY2026:
Forecast
Actual
Source: S&P Global Market Intelligence
Piramal Enterprises Ltd Performance
Day's Low
Day's High
₹1,051.45₹1,093.652 Week's Low
52 Week's High
₹736.6₹1,143.8
| Returns % | |
| 1 Month Return | + 3.95 % |
| 3 Month Return | + 3.14 % |
| 1 Year Return | + 19.73 % |
| Market Stats | |
| Previous Close | ₹1,054.95 |
| Open | ₹1,055.15 |
| Volume | 6.33L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹23,786.77Cr |
Piramal Enterprises Ltd Key Statistics
| P/E Ratio | -12.86 |
| PEG Ratio | 0.05 |
| Market Cap | ₹23,786.77 Cr |
| P/B Ratio | 0.88 |
| EPS | -74.94 |
| Dividend Yield | 1.18 |
| Sector | Finance |
| ROE | 3.5 |
Piramal Enterprises Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| ₹23,786.77 Cr | -7.96% | 0.63 | -₹1,684 Cr | ₹10,110 Cr | ||
| HOLD | ₹3,478.19 Cr | 5.75% | 0.83 | ₹115 Cr | ₹1,395 Cr | |
| BUY | ₹9,544.72 Cr | 21.2% | 0.89 | NA | NA | |
| NA | ₹195.84 Cr | 712.29% | 0.61 | NA | NA | |
| NA | ₹35.33 Cr | 75.6% | 0.50 | ₹2 Cr | ₹10 Cr |
About Piramal Enterprises Ltd
Piramal Pharma is the flagship company of Piramal Enterprises Ltd. It is a global leader in contract manufacturing and custom research services, offering a range of products and services to global customers. In the pharmaceuticals sector, Piramal Pharma manufactures and markets a wide range of generic, prescription and over-the-counter (OTC) drugs, including antibiotics, anti-inflammatory, cardiovascular, CNS, dermatology, diabetes, gastrointestinal, anti-infective, pain management and respiratory products. Piramal Capital & Housing Finance is another key business of Piramal Enterprises Ltd. It provides customized financial solutions for individuals and businesses, including home loans, loan against property, loan against securities and non-banking financial services.
Share Price: ₹1085.50 per share as on 22 Nov, 2024 04:01 PM
Market Capitalisation: ₹23,786.77Cr as of today
Revenue: ₹2,486.18Cr as on September 2024 (Q3 24)
Net Profit: ₹162.97Cr as on September 2024 (Q3 24)
Listing date: 03 Nov, 1994
Chairperson Name: Ajay G Piramal
| Organisation | Piramal Enterprises Ltd |
| Headquarters | |
| Industry | Finance |
| E-voting on shares | Click here to vote |
Key events for Piramal Enterprises Ltd
Piramal-Bain ARC Venture Exits Amid Market Challenges - 18 Nov, 2024
Piramal Enterprises and Bain Capital have surrendered their ARC license, highlighting difficulties in the distressed assets market due to regulatory hurdles and increased competition. The exit reflects a shrinking asset pool and rising capital requirements, making the ARC business less attractive.
Piramal Capital Seeks Bids for Rs 702 Crore Bad Loans - 17 Nov, 2024
Piramal Capital is inviting counterbids for two pools of non-performing loans worth Rs 702 crore through a Swiss challenge auction. The company aims to reduce its legacy book and plans to double its retail assets under management to Rs 1 trillion in three years.
Piramal Enterprises Faces Rising Risk in Business Loans - 04 Nov, 2024
Jairam Sridharan, CEO of retail lending at Piramal Enterprises, noted an increase in risk for unsecured business loans, particularly in microfinance portfolios, with a rising trend in 90-day delinquencies attributed to portfolio seasoning and macroeconomic factors.
Piramal Enterprises Reports Tripled Q2 Profit Amid Risks - 24 Oct, 2024
Piramal Enterprises' Q2FY25 net profit tripled to Rs 163 crore, driven by a 17% increase in net interest income. However, risks from a precarious credit environment were flagged, with rising non-performing assets raising concerns.
Piramal Enterprises Reports Strong Q2 Earnings Growth - 23 Oct, 2024
Piramal Enterprises announced a significant Q2 FY25 performance, with net profit tripling to Rs 163 crore and revenue increasing by 17%. However, the company flagged potential credit risks and rising delinquencies in business loans, indicating challenges ahead.
Insights on Piramal Enterprises Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPromoter Holding Up
Promoters have increased holdings from 46.03% to 46.30% in Sep 2024 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 6.26% to 7.78% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 2.25K Cr → 2.48K Cr (in ₹), with an average increase of 9.2% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 128.6% return, outperforming this stock by 187.1%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 62.6% return, outperforming this stock by 42.9%
NEGATIVE IMPACTPrice Dip
In the last 3 years, PEL stock has moved down by -58.5%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 181.48 Cr → 162.97 Cr (in ₹), with an average decrease of 10.2% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 23.94% to 23.41% in Sep 2024 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 16.19% to 14.93% in Sep 2024 quarter
Piramal Enterprises Ltd Financials
Index Inclusions
Piramal Enterprises Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 46.3% | 0.59 | |
| Foreign Institutions | 14.93% | ||
| Mutual Funds | 7.78% | 24.35 | |
| Retail Investors | 23.41% | ||
| Others | 7.58% |
Piramal Enterprises Ltd Key Indicators
Piramal Enterprises Ltd Valuation
Piramal Enterprises Ltd in the last 5 years
Lowest (-13.08x)
October 16, 2024
Today (-12.86x)
November 22, 2024
Industry (25.43x)
November 22, 2024
Highest (566.81x)
March 3, 2021
Piramal Enterprises Ltd Earnings and Dividends
Piramal Enterprises Ltd Earnings Results
Piramal Enterprises Ltd’s net profit jumped 238.18% since last year same period to ₹162.97Cr in the Q2 2024-2025. On a quarterly growth basis, Piramal Enterprises Ltd has generated -10.2% fall in its net profits since last 3-months.
Read More about Earnings ResultsPiramal Enterprises Ltd Dividends May,2024
In the quarter ending March 2024, Piramal Enterprises Ltd has declared dividend of ₹10 - translating a dividend yield of 0.92%.
Read More about Dividends
Piramal Enterprises Ltd Technicals Summary
Bearish
Neutral
Bullish
Piramal Enterprises Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Piramal Enterprises Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Piramal Enterprises Ltd shares.
Piramal Enterprises Ltd (PEL) share price today is ₹1085.5
Piramal Enterprises Ltd is listed on NSE
Piramal Enterprises Ltd is listed on BSE
- Today’s highest price of Piramal Enterprises Ltd is ₹1093.6.
- Today’s lowest price of Piramal Enterprises Ltd is ₹1051.45.
PE Ratio of Piramal Enterprises Ltd is -12.86
PE ratio = Piramal Enterprises Ltd Market price per share / Piramal Enterprises Ltd Earnings per share
Today’s traded volume of Piramal Enterprises Ltd(PEL) is 6.33L.
Today’s market capitalisation of Piramal Enterprises Ltd(PEL) is ₹23786.77Cr.
| Piramal Enterprises Ltd(PEL | Price |
|---|---|
52 Week High | ₹1143.8 |
52 Week Low | ₹736.6 |
Piramal Enterprises Ltd(PEL) share price is ₹1085.5. It is down -5.10% from its 52 Week High price of ₹1143.8
Piramal Enterprises Ltd(PEL) share price is ₹1085.5. It is up 47.37% from its 52 Week Low price of ₹736.6
| Piramal Enterprises Ltd(PEL | Returns |
|---|---|
1 Day Returns | 30.55% |
1 Month Returns | 3.95% |
3 Month Returns | 3.14% |
1 Year Returns | 19.73% |